For the first time, we’re hearing directly from one of the few women in the country who received that vaccine as part of a ...

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine. Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center and ...

An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the vaccine candidate appeared to be safe and produced a clear immune response ...

The updated guideline also strongly recommends RSV vaccination in adults and adolescents with compromised immunity. RSV ...

In "Beyond Diagnosis: Vaccines," Cleveland Clinic infectious disease specialist Donald Dumford III, MD, and host John Mangels continue their conversations on communicating effectively and ...

Donna Gustafson had a harder time than usual shaking off the jet lag from her 22-hour journey from Florida to Australia. Two days into her trip, her skin took on the yellow hue of jaundice. Subscribe ...

All nine patients treated at Dana-Farber Cancer Institute in a phase 1 trial of a personalized cancer vaccine for patients with stage III or IV kidney cancer with a high risk of recurrence, generated ...

Matthias Girndt, MD, shares vaccine best practices for patients with chronic kidney disease, including posttransplant cases.

Increased risk for hypertensive disorders was present, but modest, in a new surveillance analysis of a bivalent respiratory syncytial virus (RSV) prefusion F subunit-based (RSVpreF) vaccine for ...

There is certainly some room for debate on this question, which highlights some of the limitations of both the evidence for efficacy of newer vaccine products as well as what clinicians and patients ...

From standing orders to automated reminders and robust storage protocols, smarter vaccine workflows are helping clinics protect more patients while saving staff time. These strategies streamline care, ...

There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine. Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center and ...